Dexamethasone Market
                     Dexamethasone Market Report 2021 | By Product, Application, Top Key 
Players And Industry Outlook 2031
Dexamethasone Market by Route of Administration [Oral, Parenteral, and 
Topical], Application [Asthma, Rheumatoid Arthritis, COVID-19, and Ulcerative 
Colitis], Distribution Channel [Hospitals Pharmacy, Retail Pharmacy, and Online 
Pharmacy] – Global Outlook & Forecast 2021-2031 
According to the deep-dive market assessment study conducted by 
Growth+Reports, the global dexamethasone market was pegged at ~US$ 500
million in 2020. The market is expected to witness a CAGR of ~6% from 2021 to 
2031.  
The rapid spread of coronavirus disease (COVID-19) across almost every country 
worldwide, has resulted in severe outcomes, across all these regions. The first 
case of COVID-19 was found in Dec 2019, by the end of Dec 2020, the count has 
surged to more than 90.3 million globally. Dexamethasone is a medicine that 
decreases inflammation by producing anti-inflammatory hormones by the human
body. To fight off the novel coronavirus, the body’s immune system causes 
inflammation to occur. In its response, the immune system sometimes goes into 
overdrive (proving to be fatal in some cases) and dexamethasone helps to calm 
this effect. A randomized, controlled clinical trial in the United Kingdom has 
found dexamethasone can save the lives of people seriously ill with COVID-19. 
Shortly after the results were released, the U.K government immediately 
authorized the use of dexamethasone for patients hospitalized with COVID-19 
who required oxygen, including those on ventilators. 
To access the Sample PDF of this research study, please request here: 
https://growthplusreports.com/inquiry/request-sample/dexamethasone-market/7637
The report includes an in-depth study of the global market Dexamethasone, where segments and 
sub-segments are analysed in quite a detail. This research will help players focus on high-growth 
segments and modify their business strategies if needed. The Diabetes Care Devices global market is 
segmented based on Products, Technology, and End Users. The regional segmentation research 
presented in the report provides players with valuable insights and data regarding key geographic 
markets such as North America, Europe, Asia Pacific, and the Rest of the World (RoW). Our 
researchers and analysts use reliable primary and secondary sources for research and data.
Some of the prominent players operating in the dexamethasone market includes: -
 Novartis AG
 Pfizer Inc
 Cadila Pharmaceuticals
 Sun Pharmaceutical Industries Ltd
 Allergan
 Zydus Cadila
 Fresenius Kabi USA
 GLS pharma ltd
 Hikma Pharmaceuticals Plc
 Ocular Therapeutix
Table of Contents
1. INTRODUCTION
1. Market Ecosystem
2. Geographic Scope
3. Timeline Under Consideration
1. Historical Years – 2018 & 2019
2. Base Year – 2020
3. Forecasted Years – 2021 to 2031
4. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Their Competitive Positioning (2020)
4. MARKET DYNAMICS
1. Drivers
2. Restraints/Challenges
3. Opportunities
5. GLOBAL DEXAMETHASONE MARKET – ANALYSIS & FORECAST,
BY ROUTE OF ADMINISTRATION
1. Oral
2. Parenteral
3. Topical
6. GLOBAL DEXAMETHASONE MARKET – ANALYSIS & FORECAST,
BY APPLICATION
1. Asthma
2. Rheumatoid Arthritis
3. COVID-19
4. Ulcerative Colitis
5. Others (Skin Disorders, Allergic Disorder, Etc.)
7. GLOBAL DEXAMETHASONE MARKET – ANALYSIS & FORECAST,
BY DISTRIBUTION CHANNEL
1. Hospital Pharmacy
2. Retail Pharmacy
3. Online Pharmacy
TOC Continued…
Browse the full report now: https://growthplusreports.com/report/dexamethasone-market/7637
About Us:
Growth+Reports is part of GRG Health, a global healthcare knowledge 
service company. We are proud members of EPhMRA (European 
Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary 
& primary research, market modelling & forecasting, benchmarking, 
analysis, and strategy formulation to help clients create scalable, ground-
breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative 
Healthcare Market Research Company in 2020.